These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6528179)

  • 1. [A new therapeutic approach to menstrual migraine].
    Rozenbaum H
    Rev Fr Gynecol Obstet; 1984; 79(7-9):581-3. PubMed ID: 6528179
    [No Abstract]   [Full Text] [Related]  

  • 2. Menstrual migraine: intermittent prophylaxis with a timed-release pharmacological formulation of dihydroergotamine.
    D'Alessandro R; Gamberini G; Lozito A; Sacquegna T
    Cephalalgia; 1983 Aug; 3 Suppl 1():156-8. PubMed ID: 6616598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of migraine attacks through the use of dihydroergotamine.
    Neuman M; Demarez JP; Harmey JL; Le Bastard B; Cauquil J
    Int J Clin Pharmacol Res; 1986; 6(1):11-3. PubMed ID: 3514491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of morning migraine. Clinical and biokinetic correlation of programmed-release dihydroergotamine].
    Aylward M; Chazot G; Maddock J; Schott B
    Presse Med; 1984 Jun; 13(26):1617-9. PubMed ID: 6234558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Migraine prevention with dihydroergotamine].
    Heuser B; Middendorf E
    Fortschr Med; 1985 Nov; 103(41):966-70. PubMed ID: 3905548
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prevention of migraine with retard dihydroergotamine. Results of a multicenter study in 643 patients].
    Wörz R
    Fortschr Med; 1986 Nov; 104(43):838-42. PubMed ID: 3542767
    [No Abstract]   [Full Text] [Related]  

  • 7. [Dihydroergotamine and flunarizine in the prevention of migraine. A comparative double-blind study].
    Langohr HD; Reinecke M; Gerber WD; Mangold R
    Fortschr Med; 1988 Jan; 106(2):65-6, 69-70. PubMed ID: 3278960
    [No Abstract]   [Full Text] [Related]  

  • 8. Progress in migraine: treatment with dihydroergotamine-retard.
    Mastrosimone F; Iaccarino C
    Cephalalgia; 1983 Aug; 3 Suppl 1():168-70. PubMed ID: 6616599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of migraine attacks in children with dihydroergotamine Spofa and lysenyl].
    Vajnorský J
    Cesk Pediatr; 1986 Nov; 41(11):644-7. PubMed ID: 3814243
    [No Abstract]   [Full Text] [Related]  

  • 10. Dihydroergotamine: role in the treatment of migraine.
    Schürks M
    Expert Opin Drug Metab Toxicol; 2009 Sep; 5(9):1141-8. PubMed ID: 19624283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is orally inhaled dihydroergotamine (DHE) equivalent in efficacy in migraine to intravenous DHE?
    Tfelt-Hansen P
    Headache; 2014 Feb; 54(2):383. PubMed ID: 24512579
    [No Abstract]   [Full Text] [Related]  

  • 12. Ergot derivatives in the prophylaxis of migraine: a multicentric study with a timed-release dihydroergotamine formulation.
    Martucci N; Manna V; Mattesi P; Troiani G; Manzoni GC; Lanfranchi M; Bono G; Micieli G
    Cephalalgia; 1983 Aug; 3 Suppl 1():151-5. PubMed ID: 6352046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dihydroergotamine nasal spray.
    Gijsman HJ; Ferrari MD
    Neurology; 1995 Feb; 45(2):397-8. PubMed ID: 7854552
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy, safety, and tolerability of dihydroergotamine nasal spray as monotherapy in the treatment of acute migraine. Dihydroergotamine Nasal Spray Multicenter Investigators.
    Headache; 1995 Apr; 35(4):177-84. PubMed ID: 7775172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ergot pharmacology and alternative delivery systems for ergotamine derivatives.
    Goldstein J
    Neurology; 1992 Mar; 42(3 Suppl 2):45-6. PubMed ID: 1557192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The long term use of dihydroergotamine (DHE-45) in migraine treatment (author's transl)].
    Miyazaki T
    Masui; 1978 Jan; 27(1):79-84. PubMed ID: 633616
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapeutic strategies in menstrual migraine].
    Targa C; Massons J
    Rev Neurol; 1995; 23 Suppl 2():S226-31. PubMed ID: 7497293
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of menstrual migraine.
    Mannix LK
    Neurologist; 2003 Jul; 9(4):207-13. PubMed ID: 12864931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IV dihydroergotamine therapy for migraine treatment.
    Stein M
    Ann Emerg Med; 1988 Jul; 17(7):764. PubMed ID: 3382085
    [No Abstract]   [Full Text] [Related]  

  • 20. The relation between atypical migraine and multiphasic oral contraceptives.
    Szigethy A; Dienes L
    Ther Hung; 1992; 40(4):185-8. PubMed ID: 1345027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.